Vinflunine
Javlor (vinflunine) is a small molecule pharmaceutical. Vinflunine was first approved as Javlor on 2009-09-21. It has been approved in Europe to treat transitional cell carcinoma and urologic neoplasms.
Trade Name | Javlor |
---|---|
Common Name | Vinflunine |
Indication | transitional cell carcinoma, urologic neoplasms |
Drug Class | Vinca alkaloids |